Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors

All Hormone-Producing Cell Types of the Pituitary Intermediate and Anterior Lobes Derive FromProp1-Expressing Progenitors

(2016) Shannon W. Davis et al.   ENDOCRINOLOGY

Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists

(2016) Y Greenman et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas

(2016) Roberto Würth et al.   MOLECULAR NEUROBIOLOGY

Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas andin vivoresponse to cabergoline therapy

(2015) Leonardo Vieira Neto et al.   CLINICAL ENDOCRINOLOGY

Pituitary tumors contain a side population with tumor stem cell-associated characteristics

(2015) Freya Mertens et al.   ENDOCRINE-RELATED CANCER

Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors

(2014) M Orciani et al.   CANCER GENE THERAPY

Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma

(2014) Lingchao Chen et al.   CANCER LETTERS

The Oncofetal Protein IMP3: A Useful Marker to Predict Poor Clinical Outcome in Neuroendocrine Tumors of the Lung

(2014) Alessandro Del Gobbo et al.   Journal of Thoracic Oncology

Aggressive pituitary adenomas—diagnosis and emerging treatments

(2014) Antonio Di Ieva et al.   Nature Reviews Endocrinology

Expression of the pituitary stem/progenitor marker GFRα2 in human pituitary adenomas and normal pituitary

(2014) Nestoras Mathioudakis et al.   Pituitary

Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk

(2013) Chiara Tobia et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Zebrafish as an innovative model for neuroendocrine tumors

(2013) Giovanni Vitale et al.   ENDOCRINE-RELATED CANCER

Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells

(2012) Clara V Alvarez et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Identification of CD133+ Cells in Pituitary Adenomas

(2011) Shunji Yunoue et al.   NEUROENDOCRINOLOGY

Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case–control study

(2011) Alessandra Fusco et al.   Pituitary

Pituitary stem /progenitor cells: embryonic players in the adult gland?

(2010) Hugo Vankelecom   EUROPEAN JOURNAL OF NEUROSCIENCE

Isolation of tumour stem-like cells from benign tumours

(2009) Q Xu et al.   BRITISH JOURNAL OF CANCER

The dopamine–somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways

(2009) Erika Peverelli et al.   CANCER LETTERS

Brain tumor stem cells: view from cell proliferation

(2009) Yu Yao et al.   SURGICAL NEUROLOGY

Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study

(2008) T. Florio et al.   ENDOCRINE-RELATED CANCER

SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland

(2008) T. Fauquier et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA